NIMML Institute
Business Services · Virginia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1015 Life Science Cir, Blacksburg, Virgi...Phone Number
(540) 231-6822Website
www.nimml.orgRevenue
<$5 MillionIndustry
About NIMML Institute
NIMML Institute Org Chart
Is NIMML Institute your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NIMML Institute launches new products
Congratulate Masked Content for being promoted to Masked Content at NIMML Institute
Funding: Get notified immidiatlly once NIMML Institute has new funding data
Check if NIMML Institute has recently received funding, and reach out quickly before it becomes old news!
NIMML Institute, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if NIMML Institute had a recent Job posting/layoffs
Check out if NIMML Institute is spiking on competitors!
Earning: See what the market has to say on NIMML Institute recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined NIMML Institute as Masked Content
Find 2 more new buyers
Compare Similar Companies to NIMML Institute
Compare insights from companies similar to NIMML Institute, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NIMML Institute is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NIMML Institute is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NIMML Institute.
NIMML Institute Tech Stack
A closer look at the technologies used by NIMML Institute
NIMML Institute News & Media
NIMML Institute to Present Novel Clinical and Translational Data of Omilancor in Ulcerative Colitis Patients at Digestive Disease Week 2025
BLACKSBURG, Va.--(BUSINESS WIRE)--The NIMML Institute, (“NIMML”), a 501 (c)(3) nonprofit institute dedicated to the discovery of novel precision medicines for inflammatory and autoimmune diseases, will present results from two novel studies for omilancor, a once-daily, oral, best- and first-in-class therapy in Phase 3 clinical development for ulcerative colitis (“UC”) and Phase 2 for Crohn’s disease, at Digestive Disease Week 2025. DDW 2025 will be held at the San Diego Convention Center from MThe NIMML Institute and NImmune Biopharma Announce Publication of Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus, in Clinical and Translational Science
BLACKSBURG, Va.--(BUSINESS WIRE)--The NIMML Institute, (“NIMML”), a 501 (c)(3) nonprofit research institute dedicated to the discovery of novel precision medicines for infectious and autoimmune diseases, today announced publication of positive Phase 1 clinical results for NIM-1324, a first- and potentially best-in-class once-daily, oral, systemically distributed LANCL2 agonist therapeutic for the treatment of Systemic Lupus Erythematosus (SLE). The results, published in Clinical and TranslationThe NIMML Institute and NImmune Biopharma Announce Publication of New Mechanistic Insights on the Immunometabolic Control of Systemic Lupus Erythematosus in the Journal of Immunology
BLACKSBURG, Va.--(BUSINESS WIRE)--The NIMML Institute, (“NIMML”), a 501 (c)(3) nonprofit research institute dedicated to the discovery of novel precision medicines for infectious and autoimmune diseases, today announced the publication of a seminal article that reports the mechanisms of therapeutic efficacy of NIM-1324, an orally administered LANCL2 agonist, in ameliorating the severity of Systemic Lupus Erythematosus (SLE) and addressing the unmet clinical needs of SLE patients. These novel meNIMML Institute Presents Pioneering Research on Immunometabolic Mechanisms Related to the Pharmacological Activation of LANCL Receptors at Immunology2024, the Annual Meeting of the American Association of Immunologists
BLACKSBURG, Va.--(BUSINESS WIRE)--The NIMML Institute, (“NIMML”), a 501 (c)(3) nonprofit institute dedicated to the discovery of novel precision medicines for infectious and autoimmune diseases, today announced that it will present four abstracts regarding novel mechanistic insights related to the pharmacological activation of LANCL receptors at Immunology2024, the 107th Annual Meeting of the American Association of Immunologists (“AAI”). The AAI meeting will take place at McCormick Place in Ch
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding NIMML Institute
The Nutritional Immunology and Molecular Medicine Laboratory (NIMML Institute) specializes in applying AI to understand the complex immune system. They have published groundbreaking research related to immunology and pharmacology. The institute focuses on precision medicine for autoimmune diseases and offers tools for rapidly analyzing host metabol... Read More